APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pets Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pets Anti-infective Drugs Market Analysis and Forecast 2026-2032

Report ID 174024400229 December 2025190 pages

Choose your research edition.

Industry ResearchPets Anti-infective Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pets Anti-infective Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pets Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pets Anti-infective Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pets Anti-infective Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pets Anti-infective Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pets Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pets Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pets Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pets Anti-infective Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pets Anti-infective Drugs include Bimeda Animal Health, Ceva Santé Animale, Dechra Veterinary Products, Elanco, Norbrook, Ouro Fino Saude, Vetoquinol, Virbac and Zoetis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pets Anti-infective Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pets Anti-infective Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Pets Anti-infective Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pets Anti-infective Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pets Anti-infective Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pets Anti-infective Drugs sales, projected growth trends, production technology, application and end-user industry.

Pets Anti-infective Drugs Segment by Company

Bimeda Animal Health

Ceva Santé Animale

Dechra Veterinary Products

Elanco

Norbrook

Ouro Fino Saude

Vetoquinol

Virbac

Zoetis

Zhejiang Hisun Animal Healthcare Products

Hanvet Pet Health

Wuhan Hvsen Biotechnology

Nanjing Jindun Animal

Merck

Wuhan Chopperlvya

Pets Anti-infective Drugs Segment by Type

Injection

External Use

Internal Use

Pets Anti-infective Drugs Segment by Application

Dog

Cat

Others

Pets Anti-infective Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pets Anti-infective Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pets Anti-infective Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pets Anti-infective Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. External Use Major Manufacturers Table 4. Internal Use Major Manufacturers Table 5. Global Pets Anti-infective Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Dog Major Manufacturers Table 7. Cat Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pets Anti-infective Drugs Industry Trends Table 10. Pets Anti-infective Drugs Industry Drivers Table 11. Pets Anti-infective Drugs Industry Opportunities and Challenges Table 12. Pets Anti-infective Drugs Industry Restraints Table 13. Global Pets Anti-infective Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pets Anti-infective Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pets Anti-infective Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pets Anti-infective Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Pets Anti-infective Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Pets Anti-infective Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pets Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Pets Anti-infective Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Pets Anti-infective Drugs Sales Market Share by Region (2021-2026) Table 22. Global Pets Anti-infective Drugs Sales Market Share by Region (2027-2032) Table 23. Global Pets Anti-infective Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pets Anti-infective Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pets Anti-infective Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Pets Anti-infective Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pets Anti-infective Drugs Manufacturers, Product Type & Application Table 31. Global Pets Anti-infective Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pets Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pets Anti-infective Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pets Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pets Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Pets Anti-infective Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Pets Anti-infective Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2026) Table 43. Global Pets Anti-infective Drugs Sales Market Share by Type (2027-2032) Table 44. Global Pets Anti-infective Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Pets Anti-infective Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Pets Anti-infective Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pets Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pets Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Pets Anti-infective Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Pets Anti-infective Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2026) Table 55. Global Pets Anti-infective Drugs Sales Market Share by Application (2027-2032) Table 56. Global Pets Anti-infective Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pets Anti-infective Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. Bimeda Animal Health Company Information Table 59. Bimeda Animal Health Business Overview Table 60. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio Table 62. Bimeda Animal Health Recent Development Table 63. Ceva Santé Animale Company Information Table 64. Ceva Santé Animale Business Overview Table 65. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio Table 67. Ceva Santé Animale Recent Development Table 68. Dechra Veterinary Products Company Information Table 69. Dechra Veterinary Products Business Overview Table 70. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio Table 72. Dechra Veterinary Products Recent Development Table 73. Elanco Company Information Table 74. Elanco Business Overview Table 75. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Elanco Pets Anti-infective Drugs Product Portfolio Table 77. Elanco Recent Development Table 78. Norbrook Company Information Table 79. Norbrook Business Overview Table 80. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Norbrook Pets Anti-infective Drugs Product Portfolio Table 82. Norbrook Recent Development Table 83. Ouro Fino Saude Company Information Table 84. Ouro Fino Saude Business Overview Table 85. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio Table 87. Ouro Fino Saude Recent Development Table 88. Vetoquinol Company Information Table 89. Vetoquinol Business Overview Table 90. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Vetoquinol Pets Anti-infective Drugs Product Portfolio Table 92. Vetoquinol Recent Development Table 93. Virbac Company Information Table 94. Virbac Business Overview Table 95. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Virbac Pets Anti-infective Drugs Product Portfolio Table 97. Virbac Recent Development Table 98. Zoetis Company Information Table 99. Zoetis Business Overview Table 100. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Zoetis Pets Anti-infective Drugs Product Portfolio Table 102. Zoetis Recent Development Table 103. Zhejiang Hisun Animal Healthcare Products Company Information Table 104. Zhejiang Hisun Animal Healthcare Products Business Overview Table 105. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio Table 107. Zhejiang Hisun Animal Healthcare Products Recent Development Table 108. Hanvet Pet Health Company Information Table 109. Hanvet Pet Health Business Overview Table 110. Hanvet Pet Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio Table 112. Hanvet Pet Health Recent Development Table 113. Wuhan Hvsen Biotechnology Company Information Table 114. Wuhan Hvsen Biotechnology Business Overview Table 115. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio Table 117. Wuhan Hvsen Biotechnology Recent Development Table 118. Nanjing Jindun Animal Company Information Table 119. Nanjing Jindun Animal Business Overview Table 120. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio Table 122. Nanjing Jindun Animal Recent Development Table 123. Merck Company Information Table 124. Merck Business Overview Table 125. Merck Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Merck Pets Anti-infective Drugs Product Portfolio Table 127. Merck Recent Development Table 128. Wuhan Chopperlvya Company Information Table 129. Wuhan Chopperlvya Business Overview Table 130. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio Table 132. Wuhan Chopperlvya Recent Development Table 133. North America Pets Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Pets Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 136. North America Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 137. North America Pets Anti-infective Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 138. North America Pets Anti-infective Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 139. North America Pets Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Pets Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 142. North America Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 143. North America Pets Anti-infective Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 144. North America Pets Anti-infective Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 145. North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. North America Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 150. North America Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 151. North America Pets Anti-infective Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 152. North America Pets Anti-infective Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 153. United States Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 154. Canada Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 155. Europe Pets Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Pets Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 158. Europe Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 159. Europe Pets Anti-infective Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 160. Europe Pets Anti-infective Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 161. Europe Pets Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Pets Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 164. Europe Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 165. Europe Pets Anti-infective Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 166. Europe Pets Anti-infective Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 171. Europe Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 172. Europe Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 173. Europe Pets Anti-infective Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 174. Europe Pets Anti-infective Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 175. Germany Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 176. France Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 177. U.K. Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 178. Italy Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 180. Nordic Countries Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 181. China Pets Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 182. China Pets Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 183. China Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 184. China Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 185. China Pets Anti-infective Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 186. China Pets Anti-infective Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 187. China Pets Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 188. China Pets Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 189. China Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 190. China Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 191. China Pets Anti-infective Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 192. China Pets Anti-infective Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Asia Pets Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 194. Asia Pets Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 195. Asia Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 196. Asia Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 197. Asia Pets Anti-infective Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 198. Asia Pets Anti-infective Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 199. Asia Pets Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 200. Asia Pets Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 201. Asia Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 202. Asia Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 203. Asia Pets Anti-infective Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 204. Asia Pets Anti-infective Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 205. Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Asia Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. Asia Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 210. Asia Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 211. Asia Pets Anti-infective Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 212. Asia Pets Anti-infective Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Japan Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 214. South Korea Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 215. India Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 216. Australia Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 217. China Taiwan Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 218. Southeast Asia Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 219. SAMEA Pets Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 220. SAMEA Pets Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 221. SAMEA Pets Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 222. SAMEA Pets Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 223. SAMEA Pets Anti-infective Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 224. SAMEA Pets Anti-infective Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 225. SAMEA Pets Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 226. SAMEA Pets Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 227. SAMEA Pets Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 228. SAMEA Pets Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 229. SAMEA Pets Anti-infective Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 230. SAMEA Pets Anti-infective Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 231. SAMEA Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. SAMEA Pets Anti-infective Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. SAMEA Pets Anti-infective Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. SAMEA Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 235. SAMEA Pets Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 236. SAMEA Pets Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 237. SAMEA Pets Anti-infective Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 238. SAMEA Pets Anti-infective Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 239. Brazil Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 240. Argentina Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 241. Chile Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 242. Colombia Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 243. Peru Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 244. Saudi Arabia Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 245. Israel Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 246. UAE Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 247. Turkey Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 248. Iran Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 249. Egypt Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Table 250. Key Raw Materials Table 251. Raw Materials Key Suppliers Table 252. Pets Anti-infective Drugs Distributors List Table 253. Pets Anti-infective Drugs Customers List Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. Pets Anti-infective Drugs Image Figure 2. Global Pets Anti-infective Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pets Anti-infective Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. External Use Image Figure 6. Internal Use Image Figure 7. Global Pets Anti-infective Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pets Anti-infective Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Dog Image Figure 10. Cat Image Figure 11. Others Image Figure 12. Global Pets Anti-infective Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pets Anti-infective Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Pets Anti-infective Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pets Anti-infective Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pets Anti-infective Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Pets Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 18. Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Pets Anti-infective Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pets Anti-infective Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Pets Anti-infective Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Pets Anti-infective Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Pets Anti-infective Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Pets Anti-infective Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Pets Anti-infective Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pets Anti-infective Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pets Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pets Anti-infective Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Pets Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Pets Anti-infective Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Pets Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pets Anti-infective Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Pets Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Pets Anti-infective Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Pets Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 41. North America Pets Anti-infective Drugs Sales Share by Type (2021-2032) Figure 42. North America Pets Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 43. North America Pets Anti-infective Drugs Sales Share by Application (2021-2032) Figure 44. North America Pets Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 45. North America Pets Anti-infective Drugs Sales Share by Country (2021-2032) Figure 46. Europe Pets Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Pets Anti-infective Drugs Sales Share by Type (2021-2032) Figure 48. Europe Pets Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Pets Anti-infective Drugs Sales Share by Application (2021-2032) Figure 50. Europe Pets Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Pets Anti-infective Drugs Sales Share by Country (2021-2032) Figure 52. China Pets Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 53. China Pets Anti-infective Drugs Sales Share by Type (2021-2032) Figure 54. China Pets Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 55. China Pets Anti-infective Drugs Sales Share by Application (2021-2032) Figure 56. Asia Pets Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Pets Anti-infective Drugs Sales Share by Type (2021-2032) Figure 58. Asia Pets Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Pets Anti-infective Drugs Sales Share by Application (2021-2032) Figure 60. Asia Pets Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Pets Anti-infective Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Pets Anti-infective Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Pets Anti-infective Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Pets Anti-infective Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Pets Anti-infective Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Pets Anti-infective Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Pets Anti-infective Drugs Sales Share by Country (2021-2032) Figure 68. Pets Anti-infective Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pets Anti-infective Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • External Use
  • Internal Use
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Bimeda Animal Health
  • Ceva Santé Animale
  • Dechra Veterinary Products
  • Elanco
  • Norbrook
  • Ouro Fino Saude
  • Vetoquinol
  • Virbac
  • Zoetis
  • Zhejiang Hisun Animal Healthcare Products
  • Hanvet Pet Health
  • Wuhan Hvsen Biotechnology
  • Nanjing Jindun Animal
  • Merck
  • Wuhan Chopperlvya

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pets Anti-infective Drugs Market by Type
  3. 1.2.1 Global Pets Anti-infective Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 External Use
  6. 1.2.4 Internal Use
  7. 1.3 Pets Anti-infective Drugs Market by Application
  8. 1.3.1 Global Pets Anti-infective Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Dog
  10. 1.3.3 Cat
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pets Anti-infective Drugs Market Dynamics
  1. 2.1 Pets Anti-infective Drugs Industry Trends
  2. 2.2 Pets Anti-infective Drugs Industry Drivers
  3. 2.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
  4. 2.4 Pets Anti-infective Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pets Anti-infective Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pets Anti-infective Drugs Revenue by Region
  3. 3.2.1 Global Pets Anti-infective Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pets Anti-infective Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Pets Anti-infective Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Pets Anti-infective Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pets Anti-infective Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pets Anti-infective Drugs Sales by Region
  9. 3.4.1 Global Pets Anti-infective Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pets Anti-infective Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Pets Anti-infective Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Pets Anti-infective Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pets Anti-infective Drugs Revenue by Manufacturers
  2. 4.1.1 Global Pets Anti-infective Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pets Anti-infective Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pets Anti-infective Drugs Sales by Manufacturers
  6. 4.2.1 Global Pets Anti-infective Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pets Anti-infective Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pets Anti-infective Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pets Anti-infective Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pets Anti-infective Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Pets Anti-infective Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pets Anti-infective Drugs Market CR5 and HHI
  16. 4.8.2 2025 Pets Anti-infective Drugs Tier 1, Tier 2, and Tier 3
5 Pets Anti-infective Drugs Market by Type
  1. 5.1 Global Pets Anti-infective Drugs Revenue by Type
  2. 5.1.1 Global Pets Anti-infective Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pets Anti-infective Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pets Anti-infective Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pets Anti-infective Drugs Sales by Type
  6. 5.2.1 Global Pets Anti-infective Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pets Anti-infective Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pets Anti-infective Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pets Anti-infective Drugs Price by Type
6 Pets Anti-infective Drugs Market by Application
  1. 6.1 Global Pets Anti-infective Drugs Revenue by Application
  2. 6.1.1 Global Pets Anti-infective Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pets Anti-infective Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pets Anti-infective Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pets Anti-infective Drugs Sales by Application
  6. 6.2.1 Global Pets Anti-infective Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pets Anti-infective Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pets Anti-infective Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pets Anti-infective Drugs Price by Application
7 Company Profiles
  1. 7.1 Bimeda Animal Health
  2. 7.1.1 Bimeda Animal Health Company Information
  3. 7.1.2 Bimeda Animal Health Business Overview
  4. 7.1.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
  6. 7.1.5 Bimeda Animal Health Recent Developments
  7. 7.2 Ceva Santé Animale
  8. 7.2.1 Ceva Santé Animale Company Information
  9. 7.2.2 Ceva Santé Animale Business Overview
  10. 7.2.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
  12. 7.2.5 Ceva Santé Animale Recent Developments
  13. 7.3 Dechra Veterinary Products
  14. 7.3.1 Dechra Veterinary Products Company Information
  15. 7.3.2 Dechra Veterinary Products Business Overview
  16. 7.3.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
  18. 7.3.5 Dechra Veterinary Products Recent Developments
  19. 7.4 Elanco
  20. 7.4.1 Elanco Company Information
  21. 7.4.2 Elanco Business Overview
  22. 7.4.3 Elanco Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Pets Anti-infective Drugs Product Portfolio
  24. 7.4.5 Elanco Recent Developments
  25. 7.5 Norbrook
  26. 7.5.1 Norbrook Company Information
  27. 7.5.2 Norbrook Business Overview
  28. 7.5.3 Norbrook Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Norbrook Pets Anti-infective Drugs Product Portfolio
  30. 7.5.5 Norbrook Recent Developments
  31. 7.6 Ouro Fino Saude
  32. 7.6.1 Ouro Fino Saude Company Information
  33. 7.6.2 Ouro Fino Saude Business Overview
  34. 7.6.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
  36. 7.6.5 Ouro Fino Saude Recent Developments
  37. 7.7 Vetoquinol
  38. 7.7.1 Vetoquinol Company Information
  39. 7.7.2 Vetoquinol Business Overview
  40. 7.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
  42. 7.7.5 Vetoquinol Recent Developments
  43. 7.8 Virbac
  44. 7.8.1 Virbac Company Information
  45. 7.8.2 Virbac Business Overview
  46. 7.8.3 Virbac Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Virbac Pets Anti-infective Drugs Product Portfolio
  48. 7.8.5 Virbac Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Pets Anti-infective Drugs Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
  55. 7.10 Zhejiang Hisun Animal Healthcare Products
  56. 7.10.1 Zhejiang Hisun Animal Healthcare Products Company Information
  57. 7.10.2 Zhejiang Hisun Animal Healthcare Products Business Overview
  58. 7.10.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product Portfolio
  60. 7.10.5 Zhejiang Hisun Animal Healthcare Products Recent Developments
  61. 7.11 Hanvet Pet Health
  62. 7.11.1 Hanvet Pet Health Company Information
  63. 7.11.2 Hanvet Pet Health Business Overview
  64. 7.11.3 Hanvet Pet Health Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hanvet Pet Health Pets Anti-infective Drugs Product Portfolio
  66. 7.11.5 Hanvet Pet Health Recent Developments
  67. 7.12 Wuhan Hvsen Biotechnology
  68. 7.12.1 Wuhan Hvsen Biotechnology Company Information
  69. 7.12.2 Wuhan Hvsen Biotechnology Business Overview
  70. 7.12.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product Portfolio
  72. 7.12.5 Wuhan Hvsen Biotechnology Recent Developments
  73. 7.13 Nanjing Jindun Animal
  74. 7.13.1 Nanjing Jindun Animal Company Information
  75. 7.13.2 Nanjing Jindun Animal Business Overview
  76. 7.13.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
  78. 7.13.5 Nanjing Jindun Animal Recent Developments
  79. 7.14 Merck
  80. 7.14.1 Merck Company Information
  81. 7.14.2 Merck Business Overview
  82. 7.14.3 Merck Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Merck Pets Anti-infective Drugs Product Portfolio
  84. 7.14.5 Merck Recent Developments
  85. 7.15 Wuhan Chopperlvya
  86. 7.15.1 Wuhan Chopperlvya Company Information
  87. 7.15.2 Wuhan Chopperlvya Business Overview
  88. 7.15.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
  90. 7.15.5 Wuhan Chopperlvya Recent Developments
8 North America
  1. 8.1 North America Pets Anti-infective Drugs Market Size by Type
  2. 8.1.1 North America Pets Anti-infective Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Pets Anti-infective Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Pets Anti-infective Drugs Price by Type (2021-2032)
  5. 8.2 North America Pets Anti-infective Drugs Market Size by Application
  6. 8.2.1 North America Pets Anti-infective Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Pets Anti-infective Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Pets Anti-infective Drugs Price by Application (2021-2032)
  9. 8.3 North America Pets Anti-infective Drugs Market Size by Country
  10. 8.3.1 North America Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pets Anti-infective Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pets Anti-infective Drugs Market Size by Type
  2. 9.1.1 Europe Pets Anti-infective Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pets Anti-infective Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Pets Anti-infective Drugs Price by Type (2021-2032)
  5. 9.2 Europe Pets Anti-infective Drugs Market Size by Application
  6. 9.2.1 Europe Pets Anti-infective Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pets Anti-infective Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Pets Anti-infective Drugs Price by Application (2021-2032)
  9. 9.3 Europe Pets Anti-infective Drugs Market Size by Country
  10. 9.3.1 Europe Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pets Anti-infective Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Pets Anti-infective Drugs Market Size by Type
  2. 10.1.1 China Pets Anti-infective Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Pets Anti-infective Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Pets Anti-infective Drugs Price by Type (2021-2032)
  5. 10.2 China Pets Anti-infective Drugs Market Size by Application
  6. 10.2.1 China Pets Anti-infective Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Pets Anti-infective Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Pets Anti-infective Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pets Anti-infective Drugs Market Size by Type
  2. 11.1.1 Asia Pets Anti-infective Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pets Anti-infective Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Pets Anti-infective Drugs Price by Type (2021-2032)
  5. 11.2 Asia Pets Anti-infective Drugs Market Size by Application
  6. 11.2.1 Asia Pets Anti-infective Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pets Anti-infective Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Pets Anti-infective Drugs Price by Application (2021-2032)
  9. 11.3 Asia Pets Anti-infective Drugs Market Size by Country
  10. 11.3.1 Asia Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pets Anti-infective Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pets Anti-infective Drugs Market Size by Type
  2. 12.1.1 SAMEA Pets Anti-infective Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pets Anti-infective Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pets Anti-infective Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Pets Anti-infective Drugs Market Size by Application
  6. 12.2.1 SAMEA Pets Anti-infective Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pets Anti-infective Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pets Anti-infective Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Pets Anti-infective Drugs Market Size by Country
  10. 12.3.1 SAMEA Pets Anti-infective Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pets Anti-infective Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pets Anti-infective Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pets Anti-infective Drugs Value Chain Analysis
  2. 13.1.1 Pets Anti-infective Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pets Anti-infective Drugs Production Mode & Process
  6. 13.2 Pets Anti-infective Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pets Anti-infective Drugs Distributors
  9. 13.2.3 Pets Anti-infective Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst